Ligand Pharmaceuticals to host annual investor day
LGND•Ligand Pharmaceuticals will host its annual Investor Day on December 8, 2026, at the Harvard Club of New York City, with presentations on strategy, royalty investments and its long-term financial outlook.
1. Investor day agenda
Ligand Pharmaceuticals will host its annual Investor Day on December 8, 2026, at the Harvard Club of New York City. Presentations will cover strategy, royalty investments and the long-term financial outlook, and Palvella Therapeutics CEO Wes Kaupinen will discuss progress on QTORIN rapamycin, a treatment in development for rare diseases.
